世界の糖尿病非インスリン療法市場:販売動向2017

QYResearchが発行した調査報告書(QYR70324136)
◆英語タイトル:Global Non-Insulin Therapies for Diabetes Sales Market Report 2017
◆商品コード:QYR70324136
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年1月27日
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、糖尿病非インスリン療法の世界市場について調査・分析し、糖尿病非インスリン療法のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、糖尿病非インスリン療法産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・糖尿病非インスリン療法市場概要
・糖尿病非インスリン療法のメーカー別販売量・メーカー別シェア
・糖尿病非インスリン療法の世界市場:種類別販売量・市場シェア
・糖尿病非インスリン療法の世界市場:用途別販売量・市場シェア
・糖尿病非インスリン療法の世界市場:地域別販売量・市場シェア
・糖尿病非インスリン療法のアメリカ市場規模
・糖尿病非インスリン療法の中国市場規模
・糖尿病非インスリン療法のヨーロッパ市場規模
・糖尿病非インスリン療法の日本市場規模
・糖尿病非インスリン療法の東南アジア市場規模
・糖尿病非インスリン療法のインド市場規模
・糖尿病非インスリン療法のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・糖尿病非インスリン療法のコスト分析・価格動向
・糖尿病非インスリン療法の産業チェーン(サプライチェーン分析)
・糖尿病非インスリン療法のマーケティング戦略・販売チャネル、流通業者
・糖尿病非インスリン療法市場への影響要因分析
・糖尿病非インスリン療法の世界市場予測
・糖尿病非インスリン療法のアメリカ市場予測
・糖尿病非インスリン療法の中国市場予測
・糖尿病非インスリン療法のヨーロッパ市場予測
・糖尿病非インスリン療法の日本市場予測
・糖尿病非インスリン療法の東南アジア市場予測
・糖尿病非インスリン療法のインド市場予測
・糖尿病非インスリン療法の種類別世界市場予測
・糖尿病非インスリン療法の用途別世界市場予測
...
【レポートの概要】

Notes:Sales, means the sales volume of Non-Insulin Therapies for Diabetes
Revenue, means the sales value of Non-Insulin Therapies for Diabetes

This report studies sales (consumption) of Non-Insulin Therapies for Diabetes in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Non-Insulin Therapies for Diabetes in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Alpha-Glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides/Meglitinides
GLP-1 Analogs/GLP-1 Agonists
Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
Sulfonylureas
Thiazolidinediones
Others
Split by applications, this report focuses on sales, market share and growth rate of Non-Insulin Therapies for Diabetes in each application, can be divided into
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

【レポートの目次】

Table of Contents

Global Non-Insulin Therapies for Diabetes Sales Market Report 2017
1 Non-Insulin Therapies for Diabetes Overview
1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes
1.2 Classification of Non-Insulin Therapies for Diabetes
1.2.1 Alpha-Glucosidase Inhibitors
1.2.2 Amylin Agonists
1.2.3 Biguanides
1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.5 Glinides/Meglitinides
1.2.6 GLP-1 Analogs/GLP-1 Agonists
1.2.7 Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
1.2.8 Sulfonylureas
1.2.9 Thiazolidinediones
1.2.10 Others
1.3 Application of Non-Insulin Therapies for Diabetes
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacy
1.3.4 Others
1.4 Non-Insulin Therapies for Diabetes Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Non-Insulin Therapies for Diabetes (2012-2022)
1.5.1 Global Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)
1.5.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

2 Global Non-Insulin Therapies for Diabetes Competition by Manufacturers, Type and Application
2.1 Global Non-Insulin Therapies for Diabetes Market Competition by Manufacturers
2.1.1 Global Non-Insulin Therapies for Diabetes Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Share by Manufacturers (2012-2017)
2.2 Global Non-Insulin Therapies for Diabetes (Volume and Value) by Type
2.2.1 Global Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)
2.2.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
2.3 Global Non-Insulin Therapies for Diabetes (Volume and Value) by Regions
2.3.1 Global Non-Insulin Therapies for Diabetes Sales and Market Share by Regions (2012-2017)
2.3.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Regions (2012-2017)
2.4 Global Non-Insulin Therapies for Diabetes (Volume) by Application

3 United States Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
3.1 United States Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
3.1.1 United States Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
3.1.2 United States Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
3.1.3 United States Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
3.2 United States Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
3.3 United States Non-Insulin Therapies for Diabetes Sales and Market Share by Type
3.4 United States Non-Insulin Therapies for Diabetes Sales and Market Share by Application

4 China Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
4.1 China Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
4.1.1 China Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
4.1.2 China Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
4.1.3 China Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
4.2 China Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
4.3 China Non-Insulin Therapies for Diabetes Sales and Market Share by Type
4.4 China Non-Insulin Therapies for Diabetes Sales and Market Share by Application

5 Europe Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
5.1 Europe Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
5.1.1 Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
5.1.2 Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
5.1.3 Europe Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
5.2 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
5.3 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Type
5.4 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Application

6 Japan Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
6.1 Japan Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
6.1.1 Japan Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
6.1.2 Japan Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
6.1.3 Japan Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
6.2 Japan Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
6.3 Japan Non-Insulin Therapies for Diabetes Sales and Market Share by Type
6.4 Japan Non-Insulin Therapies for Diabetes Sales and Market Share by Application
7 Southeast Asia Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
7.1 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
7.1.1 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
7.2 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
7.3 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Market Share by Type
7.4 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Market Share by Application
8 India Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
8.1 India Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
8.1.1 India Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
8.1.2 India Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
8.1.3 India Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
8.2 India Non-Insulin Therapies for Diabetes Sales and Market Share by Manufacturers
8.3 India Non-Insulin Therapies for Diabetes Sales and Market Share by Type
8.4 India Non-Insulin Therapies for Diabetes Sales and Market Share by Application

9 Global Non-Insulin Therapies for Diabetes Manufacturers Analysis
9.1 GSK
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.1.2.1 Alpha-Glucosidase Inhibitors
9.1.2.2 Amylin Agonists
9.1.3 GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.2.2.1 Alpha-Glucosidase Inhibitors
9.2.2.2 Amylin Agonists
9.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Sumitomo Dainippon Pharma
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.3.2.1 Alpha-Glucosidase Inhibitors
9.3.2.2 Amylin Agonists
9.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Intarcia Therapeutics
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.4.2.1 Alpha-Glucosidase Inhibitors
9.4.2.2 Amylin Agonists
9.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Servier
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.5.2.1 Alpha-Glucosidase Inhibitors
9.5.2.2 Amylin Agonists
9.5.3 Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Jiangsu Hansoh Pharmaceutical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.6.2.1 Alpha-Glucosidase Inhibitors
9.6.2.2 Amylin Agonists
9.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.7.2.1 Alpha-Glucosidase Inhibitors
9.7.2.2 Amylin Agonists
9.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Emisphere
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.8.2.1 Alpha-Glucosidase Inhibitors
9.8.2.2 Amylin Agonists
9.8.3 Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Uni-Bio Science Group
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.9.2.1 Alpha-Glucosidase Inhibitors
9.9.2.2 Amylin Agonists
9.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Takeda
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
9.10.2.1 Alpha-Glucosidase Inhibitors
9.10.2.2 Amylin Agonists
9.10.3 Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 3SBio
9.12 Merck
9.13 Dong-A Pharmaceutical
9.14 Luye Pharma Group
9.15 Eurofarma
9.16 Geropharm
9.17 Alkem Labs
9.18 SatRx
9.19 Pfizer
9.20 Jiangsu Hengrui Medicine

10 Non-Insulin Therapies for Diabetes Maufacturing Cost Analysis
10.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
10.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Non-Insulin Therapies for Diabetes Market Forecast (2017-2022)
14.1 Global Non-Insulin Therapies for Diabetes Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)
14.2 Global Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Non-Insulin Therapies for Diabetes Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Non-Insulin Therapies for Diabetes
Table Classification of Non-Insulin Therapies for Diabetes
Figure Global Sales Market Share of Non-Insulin Therapies for Diabetes by Type in 2015
Figure Alpha-Glucosidase Inhibitors Picture
Figure Amylin Agonists Picture
Figure Biguanides Picture
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Picture
Figure Glinides/Meglitinides Picture
Figure GLP-1 Analogs/GLP-1 Agonists Picture
Figure Sodium-Glucose Cotransporter2(SGLT2)Inhibitors Picture
Figure Sulfonylureas Picture
Figure Thiazolidinediones Picture
Figure Others Picture
Table Applications of Non-Insulin Therapies for Diabetes
Figure Global Sales Market Share of Non-Insulin Therapies for Diabetes by Application in 2015
Figure Hospital Pharmacy Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacy Examples
Figure Others Examples
Figure United States Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure China Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Japan Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure India Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Figure Global Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)
Figure Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)
Table Global Non-Insulin Therapies for Diabetes Sales of Key Manufacturers (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Sales Share by Manufacturers (2012-2017)
Figure 2015 Non-Insulin Therapies for Diabetes Sales Share by Manufacturers
Figure 2016 Non-Insulin Therapies for Diabetes Sales Share by Manufacturers
Table Global Non-Insulin Therapies for Diabetes Revenue by Manufacturers (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers
Table 2016 Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers
Table Global Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Sales Growth Rate by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Revenue Growth Rate by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Sales and Market Share by Regions (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Sales Share by Regions (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Regions (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Sales Growth Rate by Regions (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Regions (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Regions (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Revenue Growth Rate by Regions (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Sales and Market Share by Application (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Application (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Sales Growth Rate by Application (2012-2017)
Figure United States Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure United States Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure United States Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table United States Non-Insulin Therapies for Diabetes Sales by Manufacturers (2012-2017)
Table United States Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2012-2017)
Table United States Non-Insulin Therapies for Diabetes Sales by Type (2012-2017)
Table United States Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table United States Non-Insulin Therapies for Diabetes Sales by Application (2012-2017)
Table United States Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Figure China Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure China Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure China Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table China Non-Insulin Therapies for Diabetes Sales by Manufacturers (2012-2017)
Table China Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2012-2017)
Table China Non-Insulin Therapies for Diabetes Sales by Type (2012-2017)
Table China Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table China Non-Insulin Therapies for Diabetes Sales by Application (2012-2017)
Table China Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales by Manufacturers (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales by Application (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Figure Japan Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Japan Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Japan Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Sales by Manufacturers (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Sales by Type (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Sales by Application (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Sales by Manufacturers (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Sales by Type (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Sales by Application (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Figure India Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
Figure India Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Figure India Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
Table India Non-Insulin Therapies for Diabetes Sales by Manufacturers (2012-2017)
Table India Non-Insulin Therapies for Diabetes Market Share by Manufacturers (2012-2017)
Table India Non-Insulin Therapies for Diabetes Sales by Type (2012-2017)
Table India Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table India Non-Insulin Therapies for Diabetes Sales by Application (2012-2017)
Table India Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Table GSK Basic Information List
Table GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Sumitomo Dainippon Pharma Basic Information List
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Intarcia Therapeutics Basic Information List
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Servier Basic Information List
Table Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Servier Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Jiangsu Hansoh Pharmaceutical Basic Information List
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Emisphere Basic Information List
Table Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Emisphere Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Uni-Bio Science Group Basic Information List
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Non-Insulin Therapies for Diabetes Global Market Share (2012-2017)
Table 3SBio Basic Information List
Table Merck Basic Information List
Table Dong-A Pharmaceutical Basic Information List
Table Luye Pharma Group Basic Information List
Table Eurofarma Basic Information List
Table Geropharm Basic Information List
Table Alkem Labs Basic Information List
Table SatRx Basic Information List
Table Pfizer Basic Information List
Table Jiangsu Hengrui Medicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Insulin Therapies for Diabetes
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Non-Insulin Therapies for Diabetes Industrial Chain Analysis
Table Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
Table Major Buyers of Non-Insulin Therapies for Diabetes
Table Distributors/Traders List
Figure Global Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
Figure Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Sales Forecast by Regions (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の糖尿病非インスリン療法市場:販売動向2017(Global Non-Insulin Therapies for Diabetes Sales Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆